Пробіотики в дерматології
DOI:
https://doi.org/10.30978/UJDVK2019-2-99Ключові слова:
пробіотики, пребіотики, шкіра, запалення, атопічний дерматит, старіння шкіриАнотація
Пробіотики — це живі мікроорганізми, які при введенні в адекватних кількостях можуть принести користь для здоров’я господаря. Ми вже знаємо, що їх використання позитивно впливає на ключові чинники в розвитку дерматологічних захворювань, таких як окиснювальний стрес або запалення. Найбільш популярне використання пробіотиків у дерматології відноситься до атопічного дерматиту (AД). Оскільки вже продемонстровано і широко визнано, що пробіотики можуть допомогти знизити частоту і тяжкість АД у дітей грудного віку, потрібно ще багато досліджувати його користь при лікуванні АД у немовлят/дітей, а також і у дорослих. Аналогічним чином багатообіцяючі дані показують, що пробіотики можуть допомогти при вугровій висипці, в загоєнні ран і відновленні тканин. Набагато менше або навіть нічого не відомо про їх потенційний ефект при інших запальних захворюваннях, таких як розацеа або псоріаз. Крім продемонстрованої активності в галузі фотозахисту, пробіотики, мабуть, ефективні для профілактики і навіть лікування старіння шкіри і її більш частих симптомів, таких як втрата колагену, сухість і порушення бар’єрної функції. З огляду на особливий статус шкіри її доступ для місцевого нанесення препаратів, пробіотики можуть використовуватися як системно, так і локально.
Нормалізація мікрофлори кишечника з використанням пробіотиків і пребіотиків робить позитивний вплив на деякі шкірні захворювання.
Попереду ще довгий і багатообіцяючий шлях для дослідження, перш ніж пробіотики стануть щоденним рецептом в дерматології.
Ми перебуваємо на попередній стадії при використанні пробіотиків у дерматології, і ще потрібно багато досліджень. Одного разу пробіотики стануть частиною дерматологічного рецепта.
Посилання
Food and Agriculture Organization of the United Nations, World Health Organization. Probiotics in food: health and nutritional properties and guidelines for evaluation. Rome: Food and Agriculture Organization of the United Nations: World Health Organization; 2006.
Agostoni C, Axelsson I, Goulet O, et al. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN. Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:465-73.
Prisciandaro LD, Geier MS, Chua AE, et al. Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support Care Cancer. 2012;20:3205-3210.
Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, et al. Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLoS ONE. 2012;7:e43197. doi: 10.1371/journal.pone.0043197.
Mann ER, You J, Horneffer-van der Sluis V, Bernardo D, Omar Al-Hassi H, Landy J, Peake ST, Thomas LV, Tee CT, Lee GH, et al. Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain Lactobacillus casei Shirota. Mediators Inflamm. 2013;2013:573-576. doi: 10.1155/2013/573576.
Wachi S, Kanmani P, Tomosada Y, et al. Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced inflammatory response in porcine intestinal epitheliocytes via Toll-like receptor‑2 and 4. Mol Nutr Food Res. 2014;58:2080-2093.
Wu Y, Zhu C, Chen Z, et al. Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells. Vet Immunol Immunopathol. 2016;172:55-63.
Widyarman AS, Drestia AM, Bachtiar EW, et al. The Anti-inflammatory Effects of Glycerol-supplemented Probiotic Lactobacillus reuteri on Infected Epithelial cells In vitro. Contemp Clin Dent. 2018;9(2):298-303.
Lin MY, Yen CL. Antioxidative ability of lactic acid bacteria. J Agric Food Chem. 1999;47:1460-1466.
Lee J., Hwang KT, Chung M.Y, et al. Resistance of Lactobacillus casei KCTC3260 to reactive oxygen species (ROS): Role for a metal ion chelating effect. J Food Sci. 2005;70:388-391.
Ahire JJ,Mokashe NU, Patil, et al. Antioxidative potential of folate producing probiotic Lactobacillus helveticus CD6. J Food Sci Technol. 2013;50:26-34.
Kullisaar T, Zilmer M, Mikelsaar M, et al. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbial. 2002;72:215-224.
De LeBlanc AM, LeBlanc JG, Perdigon G, et al. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol. 2008;57:100-105.
Wang AN, Yi XW, Yu HF, et al. Free radical scavenging activity of Lactobacillus fermentum in vitro and its antioxidative effect on growing-finishing pigs. J Appl Microbiol. 2009;107:1140-1148.
Strozzi GP, Mogna L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol. 2008;42:179-184.
Wang LX, Liu K, Gao DW, et al. Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice. World J Gastroenterol. 2013;19:3150-3156.
Gao D, Gao Z, Zhu G. Antioxidant effects of Lactobacillus plantarum via activation of transcription factor Nrf2. Food Funct. 2013;4:982-989.
Srivastava SK, Yadav UC, Reddy AB, et al. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem Biol Interact. 2011;191:330-338.
Tao Y, Drabik KA, Waypa TS, et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol. 2006;290:1018-1030.
Gómez-Guzmán M, Toral M, Romero M, et al. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats. Mol Nutr Food Res. 2015;59:2326-2336.
Patel B, Kumar P, Banerjee R, et al. Lactobacillus acidophilus attenuates Aeromonas hydrophila induced cytotoxicity in catla thymus macrophages by modulating oxidative stress and inflammation. Mol Immunol. 2016;75:69-83.
Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014;71(4):814-21.
Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008;121:116-21.
Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;4:CD006475.
Doege K, Grajecki D, Zyriax BC, et al. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood - a meta-analysis. Br J Nutr. 2012;107:1-6.
Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402-14.
Panduru M, Panduru NM, Salavastru CM, et al. Probiotics and primary prevention of atopic dermatitis: ameta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol. 2015;29(2):232-42.
Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60(2):221-4.
Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(1):192-198.
Kalliomäki M, Salminen S, Poussa T, et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(4):1019-21.
Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: a doubleblind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174-80.
Kopp MV, Hennemuth I, Heinzmann A, et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850-6.
Huurre A, Laitinen K, Rautava S, et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342-8.
Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122(4):788-94.
Soh SE, Aw M, Gerez I, et al. supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy. 2009;39(4):571-8.
West CE, Hammarström ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol. 2009;20(5):430-7.
Niers L, Martín R, Rijkers G, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64(9):1349-58.
Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335-41.
Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386-93.
Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616-23.
Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66(4):509-516.
Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN 001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42(7):1071-1079.
Jensen MP, Meldrum S, Taylor AL, et al. Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol. 2012;130(5):1209-1211.
Rautava S, Kainonen E, Salminen S, et al. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355-1360.
Rozé JC, Barbarot S, Butel MJ, et al. An (alpha)-lactalbuminenriched and symbiotic-supplemented v a standard infant formula: a multicentre, double-blind, randomised trial. Br J Nutr. 2012;107:1616-22.
Ou CY, Kuo HC, Wang L, et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2012;42:1386-96.
Allen SJ, Jordan S, Storey M, et al. Probiotics and atopic ECZEMA: a double-blind randomised controlled trial. Arch Dis Child. 2012;97: 2.
West CE, Hammarström ML, Hernell O. Probiotics in primary prevention of allergic disease — follow-up at 8-9 years of age. Allergy. 2013;68(8):1015-20.
Abrahamsson TR, Jakobsson T, Björkstén B, et al. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol. 2013;24(6):556-561.
Loo EX, Llanora GV, Lu Q, et al. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol. 2014;163(1):25-28.
Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child. 2014;99(11):1014-1019.
Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int. 2014;63(4):575-585.
Cabana MD, McKean M, Caughey AB, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics. 2017;140(3):e20163000.
Li L, Han Z, Niu X, et al. Probiotic Supplementation for Prevention of Atopic Dermatitis in Infants and Children: A Systematic Review and Metaanalysis. Am J Clin Dermatol. 2018 Nov 21. doi: 10.1007/s40257-018-0404-3.
Michail SK, Stolfi A, Johnson T, et al. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008;101:508-516.
Han Y, Kim B, Ban J, et al. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol 2012;23:667-673.
Matsumoto M, Aranami A, Ishige A, et al. LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clin Exp Allergy 2007;37:358-370.
Drago L, Toscano M, De Vecchi E, et al. Changing of fecal flora and clinical effect of L. salivarius LS 01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012;46(suppl): 56-63.
Moroi M, Uchi S, Nakamura K, et al. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. J Dermatol. 2011;38:131-9.
Iemoli E, Trabattoni D, Parisotto S, et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012;46(suppl):33-40.
Muizzuddin N, Maher W, Sullivan M, et al. Physiological effect of a probiotic on skin. J Cosmet Sci. 2012;63:385-395.
Kim J, Ko Y, Park YK, et al. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutrition 2010, 26:902-909.
Siver RH. Lactobacillus for the control of acne. J Med Soc N J. 1961;58:52-3.
Di Marzio L, Cinque B, De Simone C, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J Invest Dermatol. 1999;113:98-106.
Benhadou F, Mintoff D, Schnebert B, et al. Psoriasis and Microbiota: A Systematic Review. Diseases. 2018;6(2):47.
Gueniche A, Philippe D, Bastien P, et al. Randomised double-blind placebo-controlled study of the effect of Lactobacillus paracasei NCC 2461 on skin reactivity. Benef Microbes. 2013;5:137-145.
Chen YH, Wu CS, Chao YH, et al. Lactobacillus pentosus GMNL‑77 inhibits skin lesions in imiquimod-induced psoriasis-like mice. J Food Drug Anal. 2017;25:559-566.
Reygagne P, Bastien P, Couavoux MP, et al. The positive benefit of Lactobacillus paracasei NCC 2461 ST11 in healthy volunteers with moderate to severe dandruff. Beneficial Microbes, 2017;8(5): 671-680
Sugimoto S, Ishii Y, Izawa N, et al. Photoprotective effects of Bifidobacterium breve sup-plementation against skin damage induced by ultraviolet irradiation in hairless mice. Photodermatol Photoimmunol Photomed. 2012;28:312-319.
Satoh T, Murata M, Iwabuchi N, et al. Effect of Bifidobacterium breve B‑3 on skin photoaging induced by chronic UV irradiation in mice. Beneficial Microbes, 2015;6(4): 497-504.
Gueniche A, Benyacoub J, Buetler TM, et al. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol 2006;16:511-7.
Kim HM, Lee De, Park SD, et al. Oral Administration of Lactobacillus plantarum HY7714 Protects Hairless Mouse Against Ultraviolet B-Induced PhotoagingJ. Microbiol. Biotechnol. 2014;24(11):1583-1591.
Im AR, Lee B, Kang DJ, et al. Moisturizing and Antiphotodamage Effects of Tyndallized Lactobacillus acidophilus IDCC3302. J Med Food. 2018;21(10):1-8.
Valdez JC, Peral MC, Rachid M, et al. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005;11:472-9.
Peral MC, Martinez MA, Valdez JC. Bacteriotherapy with Lactobacillus plantarum in burns. Int Wound J 2009;6:73-81.
Shirzad M, Hamedi J, Motevaseli E, et al. Anti-elastase and anti-collagenase potential of Lactobacilli exopolysaccharides on human fibroblast. Artif Cells Nanomed Biotechnol. 2018;27:1-11.
Thornfeldt CR. Chronic inflammation is etiology of extrinsic aging. J Cosmet Dermatol. 2008;7(1):78-82.
Kankaanpaa P, Suts Y, Arvillomi H, et al. Comparison of antiproliferative effects of probiotic cell extracts and glucocorticoids. Gastroenterol. 1998;11:139.
Sugimuraa T, Jounaia K, Ohshioa K, et al. Long-term administration of pDC-Stimulative Lactococcus lactis strain decelerates senescence and prolongs the lifespan of mice. Int Immunopharmacol. 2018;58:166-172.
Lee J, Yang W, Hostetler A, et al. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiology. 2016;16:69.
Benyacoub J, Bosco N, Blanchard C, et al. Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and im-pact on skin defenses. Benef Microbes. 2014;5:129-36.
Hacini-Rachinel G, Gheit H, Le Luduec JB, et al. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One. 2009;4:e4903.
Di Marzio L, Cinque B, Cupelli F, et al. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol. 2008;21:137-143.
Kim H, Kim HR, Jeong BJ, et al. Effects of Oral Intake of Kimchi-Derived Lactobacillus plantarum K8 Lysates on Skin Moisturizing. J Microbiol Biotechnol. 2015);25(1):74-80.
Miyazaki K. Hanamizu T, Iizuka R, et al. Bifidobacterium -Fermented Soy Milk Extract Stimulates Hyaluronic Acid Production in Human Skin Cells and Hairless Mouse Skin. Skin Pharmacol Appl Skin Physiol. 2003;16:108-116.
Lee DS, Huh CS, Ra J, et al. Clinical Evidence of Effects of Lactobacillus plantarum HY 7714 on Skin Aging: A Randomized, Double Blind, Placebo-Controlled Study. J Microbiol Biotechnol. 2015;25(12):2160-2168.
